Demant A/S (CPH:DEMANT)
229.00
-2.40 (-1.04%)
May 19, 2026, 11:58 AM CET
Demant Market Cap
Demant has a market cap or net worth of 48.8 billion as of May 19, 2026. Its market cap has decreased by -2.51% in one year.
Market Cap
48.80B
Enterprise Value
68.54B
Revenue
22.97B
Ranking
n/a
PE Ratio
20.66
Stock Price
229.00
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 48.80B, an increase of 2,203.12%. That is a compound annual growth rate of 10.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 48.80B | 6.46% |
| Dec 30, 2025 | 45.84B | -20.30% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.33T |
| Genmab | 103.38B |
| Coloplast | 89.91B |
| ALK-Abelló | 56.01B |
| H. Lundbeck | 39.95B |
| Zealand Pharma | 21.94B |
| Ambu A/S | 16.54B |
| Bavarian Nordic | 14.40B |